Teralys Capital puts $50 mln to work in second CTI Life Sciences fund
Teralys Capital has committed $50 million to the first close of CTI II, the second life sciences fund of Canadian venture capital firm CTI Life Sciences. As reported by peHUB Canada, the firm raised $134 million of a targeted $150 million for its fund. Other investors in CTI II included the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ and BDC Capital. The Montréal-based Teralys last November secured $279 million in the initial close of its second investment vehicle, Teralys Capital Innovation Fund.
15 January 2015•3 mins read
